Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial Intravenous Laser Therapy in Patients With AKI
Journal of Lasers in Medical Sciences,
Vol. 12 (2021),
13 February 2021
,
Page e49
Abstract
Introduction: Although intravascular laser irradiation of blood (ILIB) is deemed an innocuous and a useful technique for laser therapy, particularly when systemic effects are required, no study, to our knowledge, has been conducted on the effectiveness and innocuousness of ILIB in treating acute kidney injury (AKI).
Objective: This study aimed to assess the feasibility and outcomes of ILIB in the management of patients with AKI and comparing them with the Sham-laser group. Materials and Methods: Twenty-six patients with intra-renal AKI (24-95 years old) at Tajrish Hospitals were evaluated for enrollment eligibility in this clinical trial study. This study was conducted at the nephrology department of Shahid Beheshti University of Medical Science, Tehran, Iran, between 2018 and 2019. Based on the treatment method, the patients’ assignment to two groups (ILIB or Sham-laser) was randomly done. Demographic characteristics need for dialysis, hemoglobin and
serum biochemistry changes, serum, and urine neutrophil gelatinase-associated lipocalin (NGAL) changes, laser complications, and the hospitalization period were recorded.
Results: In terms of the baseline characteristics and biochemistry serum level, no differences were seen between the two groups. All post-treatment parameters, except the hemoglobin value, significantly improved in both groups. Urine NGAL and serum NGAL show decline from the baseline in both groups; however, the reduction slope of these parameters occurred faster in the laser group in a statistically significant manner.
Conclusion: A decline in NGAL levels in the laser group during the treatment may suggest that the ILIB can help patients with AKI recover better.
- Acute kidney injury; Acute renal failure; Biomarker; Neutrophil gelatinase-associated lipocalin; Laser
How to Cite
References
Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol. 2012 ;2(2):1303-53. doi: 10.1002/cphy.c110041
Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62-73. doi: 10.1038/ki.2014.328
Makris K, Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev. 2016;37(2):85-98.
Mandelbaum T, Scott DJ, Lee J, Mark RG, Malhotra A, Waikar SS, et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med. 2011;39(12):2659-2664. doi:10.1097/CCM.0b013e3182281f1b
Di Grande A, Giuffrida C, Carpinteri G, Narbone G, Pirrone G, Di Mauro A, et al. Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department. Eur Rev Med Pharmacol Sci. 2009;13(3):197-200.
Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc. 2009;41(1):154-7. doi: 10.1016/j.transproceed.2008.10.092
Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2010;42(1):141-50. doi: 10.1007/s11255-009-9608-z
Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52(3):595-605. doi: 10.1053/j.ajkd.2008.01.020.
Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21(6):856-63. doi: 10.1007/s00467-006-0055-0.
Cetiner S, Kahraman SA, Yücetaş S. Evaluation of low-level laser therapy in the treatment of temporomandibular disorders. Photomed Laser Surg. 2006;24(5):637-41. doi: 10.1089/pho.2006.24.637.
Kazemikhoo N, Rahbar MR, Akrami SM. Low-level laser therapy along with intravascular laser in deep pressure ulcer resistant to conventional therapies. J Skin Stem Cell. 2015;2(4): e30686. doi: 10.17795/jssc30686.
KazemiKhoo N, Ansari F. Blue or red: which intravascular laser light has more effects in diabetic patients? Lasers Med Sci. 2015;30(1):363-6. doi: 10.1007/s10103-014-1672-7.
Kazemi Khoo N, Iravani A, Arjmand M, Vahabi F, Lajevardi M, Akrami SM, et al. A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci. 2013;28(6):1527-32. doi: 10.1007/s10103-012-1247-4.
Ephraim RKD, Darkwah KO, Sakyi SA, Ephraim M, Antoh EO, Adoba P. Assessment of the RIFLE criteria for the diagnosis of Acute Kidney Injury; a retrospective study in South-Western Ghana. BMC Nephrol. 2016;17(1):99. doi:10.1186/s12882-016-0318-3.
Moskvin SV. Low-Level Laser Therapy in Russia: History, Science and Practice. J Lasers Med Sci. 2017;8(2):56-65. doi: 10.15171/jlms.2017.11.
Kaviani A, Djavid GE, Ataie-Fashtami L, Fateh M, Ghodsi M, Salami M, et al. A randomized clinical trial on the effect of low-level laser therapy on chronic diabetic foot wound healing: a preliminary report. Photomed Laser Surg. 2011;29(2):109-14. doi: 10.1089/pho.2009.2680.
Ihsan FR. Low-level laser therapy accelerates collateral circulation and enhances microcirculation. Photomed Laser Surg. 2005;23(3):289-94. doi: 10.1089/pho.2005.23.289.
Schindl, A., Schindl, M., Schön, H., Knobler, R., Havelec, L., Schindl, L. Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy. Diabetes Care. 1998; 21(4):580-584. doi: 10.2337/diacare.21.4.580
Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2009;53(3):261-6. doi: 10.1097/FJC.0b013e31819d6139.
- Abstract Viewed: 818 times
- PDF Downloaded: 329 times